Trial intelligence / Profile preview

Salbutamol and Resistance Training for Muscle Hypertrophy

NCT02551276Completed

Sponsor
University of Copenhagen
Start
Nov 2013
Primary completion
Nov 2014
Modality
Small Molecules
01

Overview

Randomised, double-blind trial in muscle atrophy comparing Salbutamol + RT with Placebo + RT (2 arms). Primary endpoint: Lean body mass at 11 weeks. Started Nov 2013; status: completed.

02

Drugs

salbutamol
03

Conditions

muscle atrophy

Beyond the preview

Go deeper on NCT02551276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02551276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call